New York, May 30 (IANS) A 21 year-old Indian-origin student was shot dead by unidentified assailants in Philadelphia, a media report said.
Jude Chacko, hailing from Kerala's Kollam district, was gunned down while he was returning from work on Sunday (local time), Khaleej Times reported.
His parents migrated to the US more than 30 years ago.
Chacko, a student who also worked part-time, was attacked by two men during a robbery attempt, the report said citing police officials.
His funeral is likely to be held at a Malankara Catholic Church in Philadelphia on Saturday.
In April this year, Saiesh Veera, a 24-year-old student from Andhra Pradesh, was shot dead by unknown men at a fuel station in Ohio.
ADVT
International
Indian-origin student shot dead by unknown men in US: Report
MORE International ARTICLES
WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.
WHO calls on Pfizer to make its COVID pill more available
Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.
Rare cases of COVID returning pose questions for Pfizer pill
CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.
CDC probing 109 liver illnesses in kids, including 5 deaths
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.
Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.